Sepsis and Organ Dysfunction. The Challenge Continues

Sepsis and Organ Dysfunction The Challenge Continues Springer-Verlag Italia Srl. A.E. Baue G. Berlot A.Gullo J.-L. Vincent (Eds) Sepsis and Organ...
Author: Juliet Osborne
2 downloads 0 Views 680KB Size
Sepsis and Organ Dysfunction The Challenge Continues

Springer-Verlag Italia Srl.

A.E. Baue G. Berlot A.Gullo J.-L. Vincent (Eds)

Sepsis and Organ Dysfunction The Challenge Continues

ORGAN FAILURE ACADEMY

Springer

A.E.

BAUE,

M.D.

Department of Surgery, Saint Louis University, Health Sciences Center, St. Louis - USA

G. BERLOT, M.D. Department of Anaesthesia, Intensive Care and Pain Therapy University of Trieste, Cattinara Hospital, Trieste - Italy

A.

GULLO,

M.D.

Department of Anaesthesia, Intensive Care and Pain Therapy University of Trieste, Cattinara Hospital, Trieste - Italy

J.-L.

VINCENT,

M.D.

Department of Intensive Care, Erasme University Hospital Free University of Brussels - Belgium 1 - 34125 TRIESTE Steering Committee A.E. Baue, M.D., Department of Surgery, Saint Louis University Health Sciences Center, St. Louis - USA

O.F.A. - ORGAN F AILURE A CADEMY, VIA B ATIISTI ,

(ITALY)

G. Berlot, M.D., Department of Anaesthesia, Intensive Care and Pain Therapy University ofTrieste, Cattinara Hospital , Trieste . Italy A. Gullo, M.D., Department of Anaesthesia, Intensive Care and Pain Therapy University of Trieste, Cattinara Hospital, Trieste - Italy L. Silvestri, M.D., Department of Anaesthesia, Intensive Care and Pain Therapy University of Trieste, Cattinara Hospital, Trieste - Italy G. Sganga, M.D. , Department of Surgery, and C.N.R. Shock Centre Catholic University of Sacro Cuore, Rome . Italy

© Springer-Verlag Italia 2000 Originally published by Springer-Verlag Italia, Milano 2000 ISBN 978-88-470-0096-4 ISBN 978-88-470-2284-3 (eBook) DOI 10.1007/978-88-470-2284-3

Library of Congress Cataloging-in-Publication Data: Applied for This work is subject to copyright. AII rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. Duplication of this publication or parts thereof is only permitted under the provisions of the Italian Copyright Law in its current version and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the Italian Copyright Law. The use of general descriptive names, registered names, trademarks, etc., in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protecti ve laws and regulations and therefore free for general use. Product liability: the publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such infonnation by consulting lhe relevant literature. Cover design: Simona Colombo, Milan

SPIN: 10753508

Table of Contents

Introduction A.E. BAUE....................................................................................................................................

11

Sepsis and Organ Dysfunction. The Challenge Continues G. BERLOT, U. LUCANGELO, AND A. GULLO ................................................................................

17

OXYGEN TRANSPORT IN SEPSIS Biochemical Regulation of the Microcirculation G.P. NOVELLI ...............................................................................................................................

37

Oxygen Supply and Consumption in Tissues A. MAYR, W. PAIK, AND W. HASIBEDER ........ ............ ...... .................. .................. ........ ...... ..........

43

Ischaemia-Reperfusion in Sepsis C. ADEMBRI, A.R. DE GAUDIO, AND G.P. NOVELLI .....................................................................

49

Mechanism of Oxygen Extraction Defect in Septic Shock W. PAlK, H. KNOTZER, AND W. HASIBEDER.. .......................... ...... ...... ........ ...... .................... .......

57

ORGAN DYSFUNCTION AND BIOHUMORAL MISMATCH IN SEPSIS Gut Perfusion in Sepsis and Shock J.F. PALIZAS .................................................................................................................................

67

Pathophysiology of Encephalopathy N. LATRONICO, G.F. BUSSI, AND A. CANDIANI.............................................................................

77

Lung Dysfunction in the Early Phase of Sepsis P. NEUMANN ..................................... '" ................... , ... ... ... ... ......... ... ......... ... ...... ... ... ... ... ... ..... ... ....

85

The Kidney in Sepsis J.A. KELLUM................................................................................................................................

91

Pathophysiology of Liver Dysfunction in Sepsis N. BRIENZA .................................................................................................................................. 103

Inflammatory Cells in Septic Shock H. ZHANG, C. HSIA, AND G. PORRO ............................................................................................. 107 SEPSIS TRIAL "Revised Terminology on Sepsis J.-L. VINCENT ............................................................................................................................... 115

VI

The Epidemiology and Outcome of Patients with Sepsis: Clear as Mud R.S. WAX, AND D.e. ANGUS .......................................................................................................

123

Are there Useful New Markers of Sepsis? K. REINHART ................................................................................................... 137

M. MEISNER, AND

A Paradigm Shift: The Bidirectional Effect of Inflammation on Bacterial Growth G.U. MEDURI ............................................................................................................................... 145 Is the Dosing and Timing of the Intervention Adequate? A.F. SUFFREDINI ........................................................................................................................... 155

Clinical Trials of Mediator-Targeted Therapy in Sepsis J.e. MARSHALL ............................................................................................................................ 161

Index ........................................................................................................................................... 175

Authors Index

Adembri C. Department of Anaesthesiology and Intensive Care, Florence University School of Medicine, Florence (Italy)

Angus D.C.

Department of Anaesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (U.S.A.)

BaueA.E.

Department of Surgery, St. Louis University Medical Centre, St. Louis, Missouri (U.S.A.)

Berlot G.

Department of Anaesthesiology and Intensive Care, Trieste University School of Medicine, Trieste (Italy)

Brienza N.

Department of Anaesthesia and Intensive Care, Bari University School of Medicine, Bari (Italy)

Bussi G.F. Department of Anaesthesia and Intensive Care, University of Brescia, Brescia (Italy)

CandianiA. Department of Anaesthesia and Intensive Care, University of Brescia, Brescia (Italy)

De Gaudio A.R.

Department of Anaesthesiology and Intensive Care, Florence University School of Medicine, Florence (Italy)

GulloA.

Department of Anaesthesiology and Intensive Care, Trieste University School of Medicine, Trieste (Italy)

Hasibeder W.

Department of Anaesthesia and General Critical Care Medicine, The Leopold Franzens University of Innsbruck, Innsbruck (Austria)

Hsia C.

Division of Respiratory Medicine, Mount Sinai Hospital, Toronto University, Toronto, Ontario (Canada)

Kellum J.A.

Department of Anaesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (U.S.A.)

Knotzer H.

Department of Anaesthesia and General Critical Care Medicine, The Leopold Franzens University of Innsbruck, Innsbruck (Austria)

Latronico N.

Department of Anaesthesia and Intensive Care, University of Brescia, Brescia (Italy)

Lucangelo U.

Department of Anaesthesiology and Intensive Care, Trieste University School of Medicine, Trieste (Italy)

Marshall J.C.

Department of Surgery, The University of Toronto, Toronto General Hospital, University Health Network, Toronto, Ontario (Canada)

VIII

MayrA. Department of Anaesthesia and General Critical Care Medicine, The Leopold Franzens University of Innsbruck, Innsbruck (Austria)

Meduri G.D.

Department of Medicine, Pulmonary and Critical Care Division, University of Tennessee Medical Centre, Memphis, Tennessee (U.S.A.)

Meisner M.

Department of Anaesthesiology and Intensive Care Therapy, University Hospital, lena (Germany)

Neumann P.

Department of Anaesthesiology, Emergency and Intensive Care Medicine, University Hospital, Giittingen (Germany)

Novelli G.P.

Department of Anaesthesiology and Intensive Care, Florence University School of Medicine, Florence (Italy)

Pajk W. Department of Anaesthesia and General Critical Care Medicine, The Leopold Franzens University of Innsbruck, Innsbruck (Austria)

Palizas J.F.

Department of Intensive Care, Bazterrica Clinic, Buenos Aires (Argentina)

Porro G.

Division of Respiratory Medicine, Mount Sinai Hospital, Toronto University, Toronto, Ontario (Canada)

Reinhart K.

Department of Anaesthesiology and Intensive Care Therapy, University Hospital, lena (Germany)

Suffredini A.F.

Department of Critical Care Medicine, National Institute of Health, Bethesda, Maryland (U.S.A.)

Vincent J.-L.

Department of Intensive Care, Free University of Bruxelles, Erasme Hospital, Bruxelles (Belgium)

Wax R.S.

Department of Anaesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (U.S.A.)

Zhang H.

Division of Respiratory Medicine, Mount Sinai Hospital, Toronto University, Toronto, Ontario (Canada)

Abbreviations

AAA, aromatic amino acids

HNP-1-3, human neutrophil peptide

ALT, alanine aminotransferase

IL-l, interleukin-l

ARDS, acute respiratory distress syndrome

INF -')', interferon-y

ARF, acute respiratory failure

iNOS, inducible NO synthase

AST, aspartate aminotransferase

I-R, ischaemia-reperfusion

ATN, acute tubular necrosis

LBP, lipopolysaccharide binding protein

ATP, adenosine-triphosphate

LOCM, low-osmolality contrast media

BAL, bronchoalveolar lavage

LPS, lipopolysaccharide

BALF, bronchoalveolar lavage fluid

MAP, mean arterial pressure

BBB, blood-brain barrier BCAA, branched chain amino acid BPI, bactericidal permeability increasing protein

CARS, compensatory anti-inflammatory response syndrome

MARS, mixed inflammatory and anti-inflammatory response syndrome

MIP-2, macrophage inflammatory protein-2 MODS, multiple organ dysfunction syndrome MOF, multiple organ failure NMMA, N-monomethyl arginine

CBF, cerebral blood flow

NO, nitric oxide

CMR02 , cerebral metabolic rate of oxygen

OR, oxygen radical

CNS, central nervous system eNOS, constitutive NO synthase CRP, C-reactive protein

CSF, cerebrospinal fluid DIC, disseminated intravascular coagulation EAA, excitatory amino acids

PAF, platelet activating factor PA0 2 , alveolar oxygen tension PE, plasmapheresis PMNs, polymorphonuclear granulocytes!cells RBF, renal blood flow RVR, renal vascular resistance

ENDOCAB, endotoxin core antibody

SAO/R, splanchnic artery occlusion and reperfusion

FOR, free oxygen radicals

SE, septic encephalopathy

GABA, y-aminobutyric acid

SIRS, systemic inflammatory response syn-

G-CSF, granulocyte colony stimulating factor

drome

GFR, glomerular filtration rate

TFPI, tissue factor pathway inhibition

GM-CSF, granulocyte-macrophage colony-

TNF, tumour necrosis factor

stimulating factor

YAP, ventilator-associated pneumonia

HDR, host defense response

XD, xanthine dehydrogenase

HMG-l, high mobility group-l protein

XO, xanthine oxidase

Suggest Documents